United States:
Upcoming CMS Clinical Diagnostic Lab Test Advisory Panel Meeting To Consider Lab Test Rates
25 September 2017
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
The Medicare Advisory Panel on Clinical Diagnostic Laboratory
Tests (CDLTs) is holding a public meeting on Monday, September 25,
2017. The Panel will discuss calendar year 2018 clinical laboratory
fee schedule codes for which CMS received no applicable information
to calculate a Medicare payment rate. The list of CDLTs that will
be discussed during the meeting is available here. During the meeting the Panel will
consider public recommendations on whether the codes should be
included on the CLFS, and if so, what method of payment should be
used to price the test codes (crosswalking or gapfilling). The
agenda with webcast and call-in information is posted here.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...